Unveiling the Prevalence of Anaemia and Its Predictors Among Adults on Highly Active Antiretroviral Therapy in the Dolutegravir Era: a Retrospective Cross-sectional Study

Author:

Zewdu Woretaw Sisay1,Zeleke Mulugeta Molla1,Ferede Yared Andargie1,Kassie Achenef Bogale1,Singh Pradeep1,Alemu Muluken Adela1,Desta Getaye Tessema1

Affiliation:

1. Debre Tabor University

Abstract

Abstract

Introduction Both HIV/AIDS and anaemia are the most pressing public health issues globally. Moreover, there is a dearth of evidence regarding the frequency, severity, and prevalence of anaemia among HIV/AIDS-positive patients receiving antiretroviral therapy in Ethiopia following the rollout of the dolutegravir-based regimen by 2019 as the preferred first-line regimen. Thus, this study is aimed at assessing the prevalence, severity, and associated factors of anaemia among adult HIV-positive ART-experienced patients in Woreta Primary Hospital (WPH). Methods A health institution-based retrospective cross-sectional study design was conducted to evaluate the prevalence and factors influencing anaemia in HIV/AIDS-positive patients from February 2019 to September 2023. Medical record abstraction tools were used to gather data. Employing initially bivariate and then multivariate logistic regression models, the data were evaluated to uncover factors linked with anaemia. The Hosmer-Lemeshow goodness-of-fit test was applied to investigate the model's validity. Results The total prevalence of anaemia was 31.5% [95% CI: 28.9–33.8]. The prevalence of mild, moderate, and severe anaemia was 20.42%, 10.38%, and 0.70%, respectively. Predictors independently linked with anaemia were: female sex (AOR: 1.08), age ≥40 years (AOR: 1.21), lived with HIV >10 years (AOR: 2.31), CD4 counts <200 cells/μL (AOR: 3.81), nonsuppressed viral load (AOR: 1.28), history of opportunistic infections (AOR: 1.54), WHO clinical stage III & IV (AOR: 1.37, & 2.23, respectively), and history of parasitic infestation (AOR: 2.81). Conclusions A sizeable proportion of subjects were found anaemic. Female sex, older age, longer periods lived with the virus, lower CD4 count, nonsuppressed viral load, history of opportunistic infections, WHO clinical stages III and IV, and history of parasitic infestation were the contributing factors. Therefore, to improve the anaemic status and living circumstances of HIV-positive patients, immediate action on the linked variable is needed.

Publisher

Springer Science and Business Media LLC

Reference49 articles.

1. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. 2011, pp. 1–6. Available from: http://www.who.int/vmnis/indicators/haemoglobin. pdf [Accessed 17 April 2024].

2. Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study;Marconi VC;AIDS Res Therapy,2010

3. HAART induced inflammation, toxicity and its determinants among HIV positive children in Addis Ababa, Ethiopia;Getaneh Y;Heliyon,2023

4. Anemia in HIV Patients Attending Highly Active Antiretroviral Therapy Clinic at Hoima Regional Referral Hospital: Prevalence, Morphological Classification, and Associated Factors;Kaudha R;HIV/AIDS - Res Palliat Care,2023

5. Profile of haematologial abnormalities of Indian HIV infected individual;Dikshit B;BMC Blood disorder,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3